)
Edge11 Sep 2026
Texas Pacific Land Corporation: Keeper of the Permian Basin
Land once granted to a failed 19th-century railroad now generates royalties for Texas Pacific Land Corporation across the Permian Basin.
Chosa Oncology
Chosa Oncology (CHOSA) investor relations material
Chosa Oncology Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2026 earnings summary27 Aug, 2026
Executive summary
Advanced Platin-DRP® from clinical validation to preparations for commercialization, with strengthened presence in the US and new international collaborations in lung cancer and breast cancer.
Presented significant clinical data at ASCO 2026, including validation of Platin-DRP® in lung and breast cancer, and established a US base in Kendall Square, Boston.
Appointed Bill Cronin to lead US commercialization efforts post-period, aiming to accelerate Platin-DRP® market introduction.
Financial highlights
Net result after financial items for Q2 2026 was -2,632 TSEK, compared to -1,967 TSEK in Q2 2025.
Earnings per share after dilution was -0.03 SEK (Q2 2025: -0.028 SEK).
Cash and cash equivalents as of June 30, 2026, amounted to 2,560 TSEK (June 30, 2025: 1,876 TSEK).
Equity as of June 30, 2026, was 19,107 TSEK (June 30, 2025: 14,467 TSEK).
Directed share issue in February 2026 raised 7.3 MSEK before transaction costs.
Outlook and guidance
Focus for H2 2026 is on translating clinical evidence into commercial value, with ambitions to establish Platin-DRP® as a precision medicine tool for platinum-based cancer therapies.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Chosa Oncology
- Proprietary technology doubles chemo efficacy, with key clinical and partnership milestones ahead.CHOSA
Investor Update - Strategic progress and positive clinical data drive momentum, supported by strengthened finances.CHOSAQ1 2026
- High Platin-DRP® scores predict longer survival for advanced NSCLC patients on platinum chemo.CHOSAStatus update
- Major clinical, financial, and strategic advances drive expanded market potential in oncology.CHOSAQ4 2025
- Significant clinical progress and strengthened financial position with new capital raised in Q3 2025.CHOSAQ3 2025
- Strong Q2 results, clinical progress, and capital raises position for key data in Q3 2025.CHOSAQ2 2025
- Q3 net loss narrowed, financials strengthened, and board expertise expanded with Prof. Hirsch.CHOSAQ3 2024
- Q2 loss narrowed and cash reserves grew as CHOSA advanced oncology partnerships and technology.CHOSAQ2 2024
- DRP® platform expansion and clinical progress drive CHOSA Oncology's Q1 2025 focus.CHOSAQ1 2025
Next Chosa Oncology earnings date
Q3 202619 Nov, 2026
Chosa Oncology
Next Chosa Oncology earnings date
Q3 202619 Nov, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage